Debate About Value Of Provenge Boils Over On Medicare Site

As Medicare analysts mull whether to pay for a $93,000 prostate cancer treatment nationwide, a debate over its worth rages in public comments to the government. Some critics have sought anonymity, fearing an online backlash. Read More...

Read the complete post at http://www.npr.org/blogs/health/2010/08/02/128930253/provenge-medicare-coverage-comments?ft=1&f=103537970


Posted Aug 02 2010, 11:30 AM by NPR Blogs: Shots - Health News Blog